New vaccines against otitis media: Projected benefits and cost-effectiveness

Pediatrics

Volumn 123, Issue 6, 2009, Pages 1452-1463

  O'Brien, Megan A ^a   Prosser, Lisa A ^b   Paradise, Jack L ^c,d   Ray, G Thomas ^e   Kulldorff, Martin ^b   Kurs Lasky, Marcia ^f   Hinrichsen, Virginia L ^b   Mehta, Jyotsna ^b   Colborn, D Kathleen ^c   Lieu, Tracy A ^b,g,h  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD PILGRIM HEALTH CARE   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f DIVISION OF RESEARCH   (United States)

^g BOSTON CHILDREN S HOSPITAL   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cost effectiveness; Otitis media; Vaccines

Indexed keywords

BACTERIAL VACCINE; HAEMOPHILUS VACCINE; PNEUMOCOCCUS VACCINE;

ARTICLE; COMPUTER MODEL; COST EFFECTIVENESS ANALYSIS; DRUG COST; HAEMOPHILUS INFLUENZAE; HUMAN; MORAXELLA CATARRHALIS; OTITIS MEDIA; PRIORITY JOURNAL; UNITED STATES; VACCINATION;

ACUTE DISEASE; BACTERIAL VACCINES; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; HAEMOPHILUS INFECTIONS; HAEMOPHILUS VACCINES; HUMANS; INFANT; MIDDLE EAR VENTILATION; MORAXELLA (BRANHAMELLA) CATARRHALIS; MORAXELLACEAE INFECTIONS; OTITIS MEDIA; OTITIS MEDIA WITH EFFUSION; PNEUMOCOCCAL VACCINES; QUALITY-ADJUSTED LIFE YEARS; UNITED STATES; VACCINES, COMBINED;

EID: 66249084557     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-1482     Document Type: Article

References (56)

1. Freid VM, Makuc DM, Rooks RN. Ambulatory health care visits by children: principal diagnosis and place of visit. Vital Health Stat 13. 1998;(137):1-23
2. Finkelstein JA, Metlay JP, Davis RL, Rifas-Shiman SL, Dowell SF, Platt R. Antimicrobial use in defined populations of infants and young children. Arch Pediatr Adolesc Med. 2000;154(4):395-400 (Pubitemid 30198490)
3. Owings MF, Kozak LJ. Ambulatory and inpatient procedures in the United States, 1996. Vital Health Stat 13. 1998;(139):1-119
4. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344(6):403-409 (Pubitemid 32128672)
5. Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J. 2003;22(1):10-16 (Pubitemid 36091771)
6. Straetemans M, Sanders EA, Veenhoven RH, Schilder AG, Damoiseaux RA, Zielhuis GA. Pneumococcal vaccines for preventing otitis media. Cochrane Database Syst Rev. 2004;(1):CD001480
7. Bluestone CD, Klein JO. Otitis Media in Infants and Children. Philadelphia, PA: W.B. Saunders Company; 2001
8. Heikkinen T, Thint M, Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med. 1999;340(4):260-264 (Pubitemid 29063267)
9. Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J. 2004;23(9):824-828
10. Block SL, Hedrick J, Harrison CJ, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J. 2004;23(9):829-833 (Pubitemid 40221025)
11. Murphy TF. Vaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges. Expert Rev Vaccines. 2005;4(6):843-853 (Pubitemid 43040905)
12. Prymula R, Peeters P, Chrobok V, et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet. 2006;367(9512):740-748 (Pubitemid 43326292)
13. Wischnack LL, Jacobson RM, Poland GA, Jacobsen SJ, Harrison JM, Murtaugh PA. The surprisingly high acceptability of low-efficacy vaccines for otitis media: a survey of parents using hypothetical scenarios. Pediatrics. 1995;95(3):350-354
14. Capra AM, Lieu TA, Black SB, Shinefield HR, Martin KE, Klein JO. Costs of otitis media in a managed care population. Pediatr Infect Dis J. 2000;19(4):354-355 (Pubitemid 30213078)
15. Poehling KA, Szilagyi PG, Grijalva CG, et al. Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine [published correction appears in Pediatrics. 2007;119(6):1270]. Pediatrics. 2007;119(4):707-715 (Pubitemid 46556669)
16. Fletcher MA, Fritzell B. Brief review of the clinical effectiveness of PREVENAR against otitis media. Vaccine. 2007;25(13):2507-2512 (Pubitemid 46394514)
17. Lieu TA, Ray GT, Black SB, et al. Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children. JAMA. 2000;283(11):1460-1468 (Pubitemid 30151825)
18. Paradise JL, Rockette HE, Colborn DK, et al. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics. 1997;99(3):318-333 (Pubitemid 27175999)
19. Paradise JL, Dollaghan CA, Campbell TF, et al. Language, speech sound production, and cognition in three-year-old children in relation to otitis media in their first three years of life. Pediatrics. 2000;105(5):1119-1130 (Pubitemid 30243794)
20. US Census Bureau; Census 2000 summary File 1, generated by Megan O'Brien; using American FactFinder; http://factfinder.census.gov. Accessed July 11, 2005
21. US Census Bureau; Current Population Survey, annual social and economic supplement 2000; generated by Megan O'Brien; using American FactFinder; http://factfinder.census.gov. Accessed July 7, 2005
22. Centers for Disease Control and Prevention. Live births by day of birth. Available at: www.cdc.gov/nchs/data/statab/t001x16.pdf. Accessed June 23, 2005
23. Casselbrant ML, Kaleida PH, Rockette HE, et al. Efficacy of antimicrobial prophylaxis and of tympanostomy tube insertion for prevention of recurrent acute otitis media: results of a randomized clinical trial. Pediatr Infect Dis J. 1992;11(4):278-286
24. Mandel EM, Rockette HE, Bluestone CD, Paradise JL, Nozza RJ. Efficacy of myringotomy with and without tympanostomy tubes for chronic otitis media with effusion. Pediatr Infect Dis J. 1992;11(4):270-277
25. Ah-Tye C, Paradise JL, Colborn DK. Otorrhea in young children after tympanostomy-tube placement for persistent middle-ear effusion: prevalence, incidence, and duration. Pediatrics. 2001;107(6):1251-1258 (Pubitemid 32525198)
26. Bureau of Labor Statistics. Consumer price index for medical care services. Available at: http://data.bls.gov/cgi-bin/surveymost. Accessed April 9, 2008
27. Drug Topics Red Book: Pharmacy's Fundamental Reference. Montvale, NJ: Thomson PDR; 2005
28. Lieu TA, Black SB, Ray P, Chellino M, Shinefield HR, Adler NE. Risk factors for delayed immunization among children in an HMO. Am J Public Health. 1994;84(10):1621-1625 (Pubitemid 24323420)
29. National Compensation Survey: Occupational Wages in the United States, June 2006. Summary 07-03. Washington, DC: US Department of Labor Statistics; 2007
30. Centers for Medicare and Medicaid Services. Medicare program; revisions to payment policies under the physician fee schedule for calendar year 2004. Final rule with comment period. Fed Regist. 2003;68(216):63195-63395
31. Centers for Medicare and Medicaid Services. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2004 rates. Final rule. Fed Regist. 2003;68(148):45345-45672
32. Lieu TA, Black SB, Ray GT, Martin KE, Shinefield HR, Weniger BG. The hidden costs of infant vaccination. Vaccine. 2000;19(1):33-41 (Pubitemid 30618952)
33. Prosser LA, Ray GT, O'Brien M, Kleinman K, Santoli J, Lieu TA. Preferences and willingness to pay for health states prevented by pneumococcal conjugate vaccine. Pediatrics. 2004;113(2):283-290 (Pubitemid 38177078)
34. Bergus GR, Lofgren MM. Tubes, antibiotic prophylaxis, or watchful waiting: a decision analysis for managing recurrent acute otitis media. J Fam Pract. 1998;46(4):304-310 (Pubitemid 28169661)
35. Centers for Disease Control and Prevention. CDC vaccine price list. Available at: www.cdc.gov/vaccines/programs/vfc/cdcvac-price-list.htm. Accessed March 20, 2008
36. Lee GM, Lebaron C, Murphy TV, Lett S, Schauer S, Lieu TA. Pertussis in adolescents and adults: should we vaccinate? Pediatrics. 2005;115(6):1675-1684 (Pubitemid 43843179)
37. Lee GM, Murphy TV, Lett S, et al. Cost effectiveness of pertussis vaccination in adults. Am J Prev Med. 2007;32(3):186-193 (Pubitemid 46216742)
38. Prosser LA, Bridges CB, Uyeki TM, et al. Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerg Infect Dis. 2006;12(10):1548-1558 (Pubitemid 44570897)
39. Goldie SJ, Kohli M, Grima D, et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst. 2004;96(8):604-615 (Pubitemid 38584984)
40. Kulasingam SL, Myers ER. Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. JAMA. 2003;290(6):781-789 (Pubitemid 37432955)
41. Rein DB, Hicks KA, Wirth KE, et al. Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States. Pediatrics. 2007;119(1). Available at: www.pediatrics.org/cgi/content/full/119/1/e12 (Pubitemid 46397800)
42. Ray GT, Butler JC, Black SB, Shinefield HR, Fireman BH, Lieu TA. Observed costs and health care use of children in a randomized, controlled trial of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2002;21(5):361-365 (Pubitemid 34532925)
43. Ray GT, Whitney CG, Fireman BH, Ciuryla V, Black SB. Costeffectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects. Pediatr Infect Dis J. 2006;25(6):494-501 (Pubitemid 43863358)
44. Gates GA. Cost-effectiveness considerations in otitis media treatment. Otolaryngol Head Neck Surg. 1996;114(4):525-530 (Pubitemid 26114246)
45. Stool SE, Field MJ. The impact of otitis media. Pediatr Infect Dis J. 1989;8(suppl 1):S11-S14 (Pubitemid 19044087)
46. Finkelstein JA, Stille C, Nordin J, et al. Reduction in antibiotic use among US children, 1996-2000. Pediatrics. 2003;112(3 pt 1):620-627
47. McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA. 2002;287(23):3096-3102 (Pubitemid 34633984)
48. Sox CM, Finkelstein JA, Ruihua Y, Kleinman K, Lieu TA. Trends in otitis media treatment failure and relapse. Pediatrics. 2008;121(4):674-679
49. Zhou F, Shefer A, Kong Y, Nuorti JP. Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004. Pediatrics. 2008;121(2):253-260
50. Lieu TA, McGuire TG, Hinman AR. Overcoming economic barriers to the optimal use of vaccines. Health Aff (Millwood). 2005;24(3):666-679
51. Auinger P, Lanphear BP, Kalkwarf HJ, Mansour ME. Trends in otitis media among children in the United States. Pediatrics. 2003;112(3 pt 1):514-520 (Pubitemid 37082099)
52. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis. 1989;160(1):83-94 (Pubitemid 19162997)
53. Veenhoven R, Bogaert D, Uiterwaal C, et al. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet. 2003;361(9376):2189- 2195 (Pubitemid 36782552)
54. van Kempen MJ, Vermeiren JS, Vaneechoutte M, et al. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative? Int J Pediatr Otorhinolaryngol. 2006;70(2):275-285 (Pubitemid 43053108)
55. Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA. 2007;298(15):1772-1778 (Pubitemid 47598445)
56. American Academy of Pediatrics. 2004/05 state reports on Medicaid, Medicare, and commercial payments by CPT code. Available at: www.aap.org/research/medmedcomm0405state.htm. Accessed September 13, 2007